0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Invited Commentary | 
Mu Xu, MD, PhD; O. Joe Hines, MD
JAMA Surg. 2015;150(8):710-711. doi:10.1001/jamasurg.2015.0702.

Original Investigation | 
Alessandro Paniccia, MD; Patrick Hosokawa, MS; William Henderson, PhD; et al.
JAMA Surg. 2015;150(8):701-710. doi:10.1001/jamasurg.2015.0668.
Includes: CME, Supplemental Content

Invited Commentary | 
David H. Berger, MD, MHCM
JAMA Surg. 2014;149(5):457-458. doi:10.1001/jamasurg.2013.4163.

Original Investigation |  FREE
Ramesh B. Batchu, PhD; Oksana Gruzdyn, BS; Ravindra B. Potti, PhD; et al.
JAMA Surg. 2014;149(5):451-457. doi:10.1001/jamasurg.2013.4113.

Invited Critique | 
Ronan Cahill, MD
JAMA Surg. 2013;148(3):231. doi:10.1001/jamasurg.2013.703.

Invited Critique | 
Steven D. Colquhoun, MD
Arch Surg. 2012;147(11):1061. doi:10.1001/jamasurg.2013.493.

Review Article |  FREE
Kevin P. Charpentier, MD
Arch Surg. 2012;147(11):1053-1061. doi:10.1001/2013.jamasurg.100.

Paper |  FREE
Daniel Vallböhmer, MD; Jeffrey H. Peters, MD; Hidekazu Kuramochi, MD; et al.
Arch Surg. 2006;141(5):476-482. doi:10.1001/archsurg.141.5.476.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Precision Medicine in Breast Cancer Care An Early Glimpse of Impact
Allison W. Kurian, MD, MSc; Christopher R. Friese, PhD, RN
JAMA Oncology
Invited Commentary  | 
Value-Based Cancer Care and the Excessive Cost of Drugs
Benjamin Djulbegovic, MD, PhD
JAMA Oncology
Original Investigation  | 
Association Between Use of the 21-Gene Recurrence Score Assay and Receipt of Chemotherapy Among Medicare Beneficiaries With Early-Stage Breast Cancer, 2005-2009
Michaela A. Dinan, PhD; Xiaojuan Mi, PhD; Shelby D. Reed, PhD; et al.
JAMA Oncology
Original Investigation  | 
Necitumumab in Metastatic Squamous Cell Lung Cancer Establishing a Value-Based Cost
Daniel A. Goldstein, MD; Qiushi Chen, BSc; Turgay Ayer, PhD; et al.